In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations

References

• Brooks PM, Day RO. Non-steroidal anti-inflammatory drugs differences and similarities. N Engl J Med 1991;324:1716–1725.
   PubMed Web of Science ®Google Scholar
• Smolinske SC, Hall AH, Vandenberg SA, Spoerke DG, McBride PV. Toxic effects of non-steroidal anti-inflammatory drugs in overdose: An overview of recent evidence on clinical effects and dose response relationships. Drug Saf 1990;5:252–274.
   PubMed Web of Science ®Google Scholar
• Loth H. Vehicular influence on transdermal drug penetration. Int J Pharm 1991;68:1–10.
   Web of Science ®Google Scholar
• TenHoor CN, Bakatselou V, Dressman J. Solubility of Mefenamic acid under simulated fed- and fasted state conditions. Pharm Res 1991;8:1203–1205.
   PubMed Web of Science ®Google Scholar
• Naito S-I Nakamori, S, Awataguchi M, Nakajima T, Tominaga H. Observations on and pharmacokinetic discussion of percutaneous absorption of mefenamic acid. Int J Pharm 1985;24:127–147.
   Google Scholar
• Schwenker G, Chen JB. 1,2-Dihydro-3,1-benzoxazin-4-one and 4H-1,2-dihydro-pyrido-[2,3-d]- [1,3]-oxazin-4-one derivatives as potential prodrugs. Part III: Permeability through excised human skin in vitro. Arch Pharm (Weinheim) 1991;324:891–894.
   PubMed Web of Science ®Google Scholar
• Taub ME, Kristensen L, Frokjaer S. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur J Pharm Sci 2002;15:331–340.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Smith LD. Solid dispersion approach to the formulation of organic liquid drugs using polyethylene glycol 6000 as a carrier. J Pharm Sci 1971;60:125–127.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Powder Technol 2004;141:187–195.
   Web of Science ®Google Scholar
• Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Theophylline particle design using chitosan by the spray drying. Int J Pharm 2004;270:167–174.
   PubMed Web of Science ®Google Scholar
• Habib MJ. Pharmaceutical solid dispersion technology. 1st ed. Lancaster, PA: Informa Healthcare; 2000.
   Google Scholar
• Nishihata T, Kamada A, Sakai K, Takahashi K, Matsumoto K, Shinozaki K, Tabata Y, Keigami M, Miyagi T, Tatsumi N. Percutaneous absorption of diclofenac in rats and humans: Aqueous gel formulation. Int J Pharm 1988;46:1–7.
   Web of Science ®Google Scholar
• USP, the United States Pharmacopoeia. 27th ed. Rockville, MD: Pharmacopoeial Convention Inc; 2004.
   Google Scholar
• Block LH. Medicated topicals. In: Remington: The science and practice of pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:871–888.
   Google Scholar
• Gallardo V, Zouaki Y, Parera A, Ruiz MA. Effect of cellulosic polymer on the release of salicylates in topical formulations. React Funct Polym 2001;50:33–40.
   Web of Science ®Google Scholar
• Buckton G, Tawburic S. Drug release from gel bases: A case for enthalpy-entropy compensation. J Control Release 1992;20:29–35.
   Web of Science ®Google Scholar
• Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
   Google Scholar
• Tas Ç, Özkan Y, Savaser A, Baykara T. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. Il Farmaco 2003;58:605–611.
   PubMedGoogle Scholar
• Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145–153.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Fujii M, Kokudai M, Noda S, Okada H, Kondoh M, Watanabe Y. Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone. J Pharm Sci 2007;96:1537–1547.
   PubMed Web of Science ®Google Scholar
• Dong Z, Chatterji A, Sandhu H, Choi DS, Chokshi H, Shah N. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. Int J Pharm 2008;355:141–149.
   PubMed Web of Science ®Google Scholar
• Pavia DL, Lampman GM, Kriz GS, Vyvyan JA. Introduction to spectroscopy. 4th ed. Independence, KY: Brooks/Cole; 2008.
   Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–1698.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Hasegawa S, Wakiyama N, Kusai A, Senna M. Comparison between polyvinyl pyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion. Int J Pharm 2003;250:283–286.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Fujii M, Sugamura Y, Yoshikawa R, Fujimoto S, Nakanishi S, Motosugi Y, Koizumi N, Yamada M, Ouchi K, Watanabe Y. The preparation of a solid dispersion powder of indomethacin with crospovidone using a twin-screw extruder or kneader. Int J Pharm 2008;365:53–60.
   PubMed Web of Science ®Google Scholar
• Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45–58.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den Mooter G. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit® E100. Eur J Pharm Biopharm 2008;70:861–868.
   PubMed Web of Science ®Google Scholar
• Delneuville I, Dechesne JP, Delattre L. Preparation and study of the characteristics of dithranol:polyvinyl pyrrolidone coevaporates. Int J Pharm 1998;168:109–118.
   Google Scholar
• Fang L, Numajiri S, Kobayashi D, Morimoto Y. The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int J Pharm 2003;262:13–22.
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Güngör S, Cevher E. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. Il Farmaco 2004;59:563–566.
   PubMedGoogle Scholar
• Fang JY, Sung KC, Hu OY, Chen HY. Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusions and iontophoresis. Arzneimittel-Forschung 2001;51:408–413.
   PubMed Web of Science ®Google Scholar
• Wang YY, Hong CT, Chiu WT, Fang JY. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm 2001;224:89–104.
   PubMed Web of Science ®Google Scholar
• Osborne DV, Amann AH. Topical drug delivery formulations. Vol. 42. New York: Marcel Dekker; 1990.
   Google Scholar
• Al-Khamis KI, Davis SS, Hadgraft J. Microviscosity and drug release from topical gel formulations. Pharm Res 1986;3:214–217.
   PubMed Web of Science ®Google Scholar
• Mohammed FA. Topical permeation characteristics of diclofenac sodium from NaCMC gels in comparison with conventional gel formulations. Drug Dev Ind Pharm 2001;27:1083–1097.
   PubMed Web of Science ®Google Scholar